New York Life Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Sell |
11,706
-480
| -4% | -$72.8K | 0.02% | 552 |
|
|
2025
Q1 | $1.83M | Buy |
12,186
+48
| +0.4% | +$7.23K | 0.02% | 556 |
|
|
2024
Q4 | $2.24M | Sell |
12,138
-926
| -7% | -$171K | 0.02% | 526 |
|
|
2024
Q3 | $2.57M | Sell |
13,064
-496
| -4% | -$97.7K | 0.03% | 515 |
|
|
2024
Q2 | $2.8M | Buy |
13,560
+1,361
| +11% | +$281K | 0.03% | 469 |
|
|
2024
Q1 | $3.31M | Buy |
12,199
+5,066
| +71% | +$1.37M | 0.03% | 433 |
|
|
2023
Q4 | $1.69M | Sell |
7,133
-5,554
| -44% | -$1.31M | 0.02% | 573 |
|
|
2023
Q3 | $2.49M | Buy |
12,687
+2,909
| +30% | +$570K | 0.03% | 462 |
|
|
2023
Q2 | $2.06M | Buy |
9,778
+2,564
| +36% | +$539K | 0.02% | 504 |
|
|
2023
Q1 | $1.46M | Buy |
7,214
+19
| +0.3% | +$3.84K | 0.02% | 564 |
|
|
2022
Q4 | $1.57M | Buy |
7,195
+11
| +0.2% | +$2.4K | 0.02% | 558 |
|
|
2022
Q3 | $1.41M | Buy |
7,184
+27
| +0.4% | +$5.31K | 0.02% | 572 |
|
|
2022
Q2 | $1.53M | Buy |
+7,157
| New | +$1.53M | 0.02% | 556 |
|